Image credit: FDA

FDA Reopens CBD Public Comment, “Extending It Indefinitely”

The Agency is specifically looking to collect “scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”

CBD
Congress, Newsletter

Outgoing Rep. Blumenauer Talks Banking, Hemp, and Trump

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.